transcribing the audiotapes -this is a lot of work -do you really need to transcribe them? Or could you measure what you want to measure direct from the audiotapes? Probably would need more rater training but might save time overall all. The recordings are however important as -if a nil result is found this analysis might identify whether the qpls had changed the consultations between surgeons and patients or whether the surgeons 'resisted' the patients attempts to gather more information. The size of the financial reward to patients is not stated -I think it should be. There are a couple of questions to be put to patients that include the word 'any' -'Did you receive any information in the mail...';'looking back on your treatment is there anything you would do differently' -the wording of these questions may bias towards an answer of 'no/nothing' -rephrasing with 'what' -'what information did you receive' 'looking back what would you do differently' might get different responses -so think about the wording. It is stated that the qualitative interviews will be with patients who suffer 'serious' post operative complications -but I couldn't find a definition of seriousthis would need to be defined before the study commences. There are some details missing to fulfil the consort checklist criteria -for example how randomisation would be conducted and by whom.
REVIEWER
Anke Steckelberg Martin-Luther-Universität Halle-Wittenberg Medical Fakulty Institute of Health and Nursing Science REVIEW RETURNED 14-Nov-2016
GENERAL COMMENTS
The authors have submitted the protocol of a cluster-randomized trial on a very interesting topic. The aim of the study is to evaluate the effect of a question prompt list with respect to patient engagement in decision making in high risk surgery. The protocol is clear and endpoints are clearly defined. There are only few issues I would like to address:
Abstracts: Although not mandatory for the abstract, the authors should rather provide the sample size calculation instead of details of the procedure.
Methods and analysis: -In the protocol surgeons (rather than clusters) will cross over into the intervention group. The authors should discuss the potential contamination.
-The authors adopted some of the questionnaires to survey family members. Could you please clarify, whether patients and family members were always interviewed separately (in one interview) and how responses were included into the analyses.
-Outcome assessment could not be blinded. Therefore study staff is asked to adhere to a study script. This procedure will at least result into an unclear risk of bias. Since the study has already started, changes will no longer be possible.
Reporting statement: The authors should provide a reporting statement.
REVIEWER

Ben Carter Kings College London, UK
REVIEW RETURNED
02-Dec-2016
GENERAL COMMENTS I congratulate the authors for tackling a very important issue and I thank them for their efforts. I offer a number of suggestions for how they can improve their study design, or consider features that could be improved.
This manuscript misses out the entire work of Professor Jane Blazeby (Bristol University, UK), which is focused on the determination of what patients what to know and what information patients receive. The work of Professor Blazeby is work leading in this area and the researchers appear to be duplicating a number of her findings. At the very least I would expect Professor Blazeby's work to be included to present the current state of te literature for a number of the objectives that the investigators are trying to repeat.
The key reason for undertaking a cluster randomised trial is to eliminate contamination between those in the intervention and usual care arm. Firstly, did the 90 surgeons involved with the development of the tool also feature in the study recruiting patients? If so, how did they unlearn the composition of the QPL, as I would imagine their usual practice would have changed following development of the QPL? Additionally, what features were put in place to prevent those surgeons delivering on the intervention arm discussing the composition of the QPL with those surgeons at the same site who were recruiting to the usual care arm. Did you balance on the expertise of the surgeon (or more likely, the time since graduation). How were the surgeons randomised within the sites? If they were just picked-by what method?
Please clarify the outcomes-in particular how are you measuring and comparing the primary outcome? Please clearly state your secondary outcomes and how they are measured.
Methods-planned analyses> Please include: How are you planning on dealing with missing data, which covariates that will you adjust for? And how were these selected? Which software are you using? What summary measures are you planning on presenting?
Sample size calculation The sample size has a number of weaknesses. Firstly, I would anticipate clustering within sites, as surgeons at similar sites will see a similar case-mix of patients and have access to similar MDT. However, this will vary across sites. This second multi-level needs to be accounted for in the sample size and the ICC for the sites needs to be considered and included.
At present the calculation is unclear and should also consider the loss of power due to unbalanced. A few references below will help and are more informative than the reference source currently stated which are very dated and not related to cRCTs. 
GENERAL COMMENTS
This paper describes the protocol for a stepped-wedge cluster randomised trial of a Question Prompt List aimed at improving decision making and informing expectations in elderly patients due to undergo high risk vascular or oncology surgery.
I think the title of the paper should include 'stepped-wedge'. The abstract does not mention 'stepped-wedge' either, nor does it mention the number of sites, surgeons or patients to be recruited. I think the abstract should also list the primary outcomes.
In the introduction, it would be helpful (p4, l18) to know what percentage of the US population is covered by Medicare.
(p6, l4) Patients due to undergo neurosurgical procedures were included in the initial sample of 90. Why does the trial population not include patients due to undergo such procedures (or are do they come under the vascular umbrella?).
In the eligibility criteria, it is unclear how patients with sight or hearing problems would be accommodated in the study.
Attrition
What will be done if surgeons move to work in a different institution? Presumably some patients will die in or shortly after surgery but no account of this has been taken in the sample size calculations.
Will reminder letters be sent to patients who do not return questionnaires? How many attempts will be made to telephone patients?
p13, l54: states that study staff will not be blinded during data collection. However, it is stated that an attempt will be made to insulate study staff from group assignment during data collection. Did the authors mean to write 'patients'? Could study staff be blinded whilst collecting chart review data? There are four primary outcomes, yet the Bonferroni correction is applied for two hypothesis tests. Should it not be applied for four? In Figure 3 , it would be helpful to add that the lower left hand part is usual approach A and the lower right hand part is usual approach B (page 14, lines 54-57) There is no mention of the CONSORT statement (extension to cluster randomised trials) in terms of trial reporting.
There is no mention of the database software that will be used for the trial database and how data will be quality checked. Thank you for your question. We agree that conflict may exist between surgeons and patients who do not undergo surgery. However, we are interested specifically in exploring the concept of surgical buyin (described on page 7), which occurs when the surgeon believes that the patient has agreed to the operative procedure as well as all the possible postoperative care. Our group has characterized this phenomenon through extensive analysis of preoperative conversations between surgeons, patients and families.1,2 For the subset of patients who experience life-threatening complications, this can create postoperative conflict when patient and/or their families wish to withhold or withdraw lifesustaining treatments that the surgeon believes the patient agreed to preoperatively.3
We built upon our prior work characterizing how patients understand the concept of surgical buy-in to generate our QPL. 3 We hypothesize that questions on the QPL such as "What happens if things go wrong?" will reduce postoperative conflict in the uncommon situation of a serious postoperative complication. As such, we chose to purposefully interview the patients and or families of those who underwent surgery and experienced a serious adverse event. In addition, due to the scope of this project we lack the resources necessary to also interview patients who suffered less severe or no complications.
2. Currently the plan is to ask the surgeon whether they generally make decisions in the 1st or 2nd consultation, and then to tape that. I wonder if it would not be better to tape the first consultation, and if a decision is not made, also the 2nd. That way decision-making will definitely not be missed.
Thank you for this comment. This was a very difficult study design decision for our group which we debated extensively. Ultimately, given our desire to compare the number of questions asked during the "decision-making conversation" it was critical to record only one conversation as recording two conversations for some patients and one conversation for another would make for a very skewed comparison.
Initially, we intended to record only the first consultation with the surgeon, recognizing most patients had been referred for a specific reason and the bulk of the decision-making conversation would happen at that time. However, after discussion with our surgeon participants, we discovered a small subset who use the first visit just to review the patient"s condition and send the patient for additional testing, such as a CT scan for cancer staging. They generally do not have a discussion about surgery during this visit. This was particularly important for our cancer surgeons who were concerned that there were many patients who came to them for a first visit with non-operable cancer; they were worried that delivery of the QPL before this visit would be cruel, prompting the patient to believe surgery was a strong possibility. It was also important for our surgeons who work in a resource poor environment and are required to do much of the preoperative workup to determine the patient"s candidacy for surgery after the patient comes for a visit. As such, we modified our study procedures to accommodate this practice pattern. We acknowledge that we will miss parts of the treatment decision for some patients with this strategy. Indeed, the notion that all surgical decision making takes place at one moment in time with one conversation is illusory to begin with, as some patients have decided not to go see a surgeon and others have decided to have surgery after talking with the doctor who diagnosed their condition.4
Reviewer: 2 Reviewer Name: Paul Kinnersley Institution and Country: Medical School, Cardiff University Please state any competing interests or state "None declared": None declared
1. Transcribing the audiotapes -this is a lot of work -do you really need to transcribe them? Or could you measure what you want to measure direct from the audiotapes? Probably would need more rater training but might save time overall all. The recordings are however important as -if a nil result is found this analysis might identify whether the qpls had changed the consultations between surgeons and patients or whether the surgeons 'resisted' the patients attempts to gather more information.
Thank you for your comment. Although transcription is a lot of work, we feel it is warranted for this study. Our research group has extensive experience with analysis of transcripts of audio recordings and we have an efficient process in place. Furthermore, given our routines, we worry that we will miss important questions/interactions in our review of the audio which goes by quickly as opposed to the visual identification of items on the transcript. We have developed a robust coding manual for the primary outcome of aim 1 which relies on the conversations in transcript form. Finally, we believe that listening to the audio-recordings could introduce bias into the coding process. It is not impossible for a coder to recognize a surgeon"s voice in the audio recording. The coder"s impressions of that surgeon or the surgeon"s communication style could influence the results. It is much less likely that a coder could identify a surgeon from the de-identified transcript alone. That said, the reviewer"s point about the surgeon"s tone and resistance to question asking is very interesting and is a strategy we will consider pursuing for subsequent analysis.
2. The size of the financial reward to patients is not stated -I think it should be.
We have included the amount of the financial award, $55, on page 12, paragraph 3, line 5.
3. There are a couple of questions to be put to patients that include the word 'any' -'Did you receive any information in the mail. Thank you for this suggestion, it is a subtle point we had not considered. We agree with the question regarding receipt of items in the mail and will omit the word "any" from this questioning. (See page 19,  Table 3 , line 8) The question about treatment associated regret is more complicated. The phrasing of this question is taken directly from a study of patients with breast cancer5 that specifically targeted the theoretical definition of regret. We worry that in re-phrasing the question we would lose the analytic guidance this interesting paper provides.
4. It is stated that the qualitative interviews will be with patients who suffer 'serious' post operative complications -but I couldn't find a definition of serious -this would need to be defined before the study commences.
Thank you. We have used a standard definition of serious complications that is used frequently in the surgical literature. This list is fairly comprehensive and general details of this are described in the first paragraph on page 13 in the section titled "Recruitment." Serious postoperative complications include prolonged hospitalization, prolonged length of stay in intensive care, prolonged mechanical ventilation, myocardial infarction, major cerebral vascular accident, new onset dialysis and death. We have added additional description about the length of hospital stay and ICU stay to increase clarity.
5. There are some details missing to fulfil the consort checklist criteria -for example how randomisation would be conducted and by whom.
Thank you for pointing this out. We added additional clarifications to the "Randomization and blinding" section on page 13, paragraph 2 to address your comments. Thank you for this suggestion. We included the sample size in the "Methods and Analysis" portion of the abstract.
2. In the protocol surgeons (rather than clusters) will cross over into the intervention group. The authors should discuss the potential contamination.
Thank you for raising this important point. Our study is designed to have individual surgeons rather than clusters cross over to the intervention; we believe that the potential for contamination is minimal. The surgeons we enroll in the study practice a variety of subspecialties such that the surgeon"s clinics are located in physically separate spaces or buildings with different clinical support staff. In addition, the number of patients who could see more than one study enrolled surgeon within the time-frame of our study is exceptionally low. We hypothesize that our intervention exerts an effect over time on the surgeon changing the overall structure of his/her communication with patients. This change is unlikely to occur if a few patients bring the QPL to a surgeon who has not yet crossed over to the intervention arm. Furthermore, the intervention requires not only the QPL, but also surgeon endorsement. Only patients of study surgeons who have crossed over to the intervention arm will receive the QPL and surgeon endorsement letter (personalized by the study surgeon, generally his/her name, signature, letter-head) in the mail prior to the consultation. Therefore, even if a patient gains access to the QPL for a surgeon in the control arm, they have not received the intervention. We added detail to the end of paragraph 1, lines 3-8 on page 14 to clarify this important point.
3. The authors adopted some of the questionnaires to survey family members. Could you please clarify, whether patients and family members were always interviewed separately (in one interview) and how responses were included into the analyses.
Thank you, this is important to clarify. We will interview patients and family members independently and have added a sentence to clarify this on page 16, lines 3-4. We have described the primary analysis of our main outcome measures which are predominantly patient-reported outcomes. Given the participation of family members is difficult to know a priori, analysis of family-reported measures is exploratory at this time. As the effect of major surgery on care-givers of older patients who are by and large family members can be profound, we believe it is critical to collect and analyze these data independent of the patient-reported outcomes. We have clarified this point on page 22, first full paragraph, line 5.
4. Outcome assessment could not be blinded. Therefore study staff is asked to adhere to a study script. This procedure will at least result into an unclear risk of bias. Since the study has already started, changes will no longer be possible.
We acknowledge there is a small risk of bias with this study procedure however we feel it is low based on how we have constructed the study script. Furthermore, we have limited the number of study personnel at each site who perform follow-up data collection to minimize this potential bias. However, we added to paragraph 2 on page 14 that an audit of 10% of the data collected from chart abstraction will be conducted by a blinded clinician. In addition, we clarified that transcriptionists and qualitative interviewers will be blinded.
Reporting statement:
The authors should provide a reporting statement.
Thank you for pointing this out. We have added a statement to the last paragraph on page 26, last line. Thank you for making us aware of Professor Blazeby"s work. We have acknowledged her contribution to this field in the end of page 6 and lines 1-2 on page 7.
2. The key reason for undertaking a cluster randomised trial is to eliminate contamination between those in the intervention and usual care arm. Firstly, did the 90 surgeons involved with the development of the tool also feature in the study recruiting patients? If so, how did they unlearn the composition of the QPL, as I would imagine their usual practice would have changed following development of the QPL?
Thank you for allowing us to clarify this important point. The 90 preoperative conversations we discuss in the section on current gaps in communication were not directly involved in the development of the QPL. We enrolled these surgeons as part of a different study to characterize current communication practices in high-risk surgical decision making.6 As such, these surgeons were not directly involved in development of the QPL. Furthermore, the surgeons involved in our primary observational studies are not enrolled in this study and four of the five institutions in this study were not involved in our preliminary observational studies.
3.
Additionally, what features were put in place to prevent those surgeons delivering on the intervention arm discussing the composition of the QPL with those surgeons at the same site who were recruiting to the usual care arm.
We agree that minimizing contamination is important. Surgeons in our study are largely unaware of the other surgeons enrolled in our study; we certainly have not disclosed to them who else is participating. While certainly possible, we expect negligible contamination between participants in different study arms. Please note, our intervention requires surgeon endorsement of the QPL. Only the patients of study enrolled surgeons will receive the QPL and surgeon endorsement letter in the mail prior to their clinic visit. Furthermore, we have enrolled only a small proportion of practicing surgeons at each site. We acknowledge that it is possible that surgeons may find out who else is enrolled by speaking to other surgeons and learn about the QPL. Given that we have enrolled surgeons from a variety of surgical departments and divisions, many of whom have entirely separate clinic staff and clinics located in different buildings, this type of contamination seems very unlikely. We have described these points on page 14, paragraph 1, lines 3-8.
4. Did you balance on the expertise of the surgeon (or more likely, the time since graduation). How were the surgeons randomised within the sites? If they were just picked-by what method?
Thank you for this question. We recorded information on the years in practice and practice volume of each surgeon participant. However, we did not explicitly balance participants on these factors as we prioritized stratified sampling based on surgeon specialty, and there are simply not enough surgeons with high patient volume to stratify sampling within these other domains. At many institutions, there are just a few surgeons in each specialty who perform a sufficient volume of high-risk surgery on older patients required for the feasibility of our study. For specialties with more than one eligible surgeon, we randomly selected which surgeons to invite to participate as described in the recruitment section on page 12, paragraph 2. Within each site, surgeon randomization for cross over into the intervention arm was performed using a computer generated randomization scheme following our stepped-wedge design. We added clarifications to the randomization process on page 13, paragraph 2.
5. Please clarify the outcomes-in particular how are you measuring and comparing the primary outcome? Please clearly state your secondary outcomes and how they are measured.
We are unclear about the reviewers concerns here. We outline all of the primary and secondary outcomes including the measurement tool and source in the text on pages 17-18 as well as Table 2 on page17. Description of the analyses for the primary and secondary outcomes are described on page 21. All outcomes are measured with well-validated and previously described strategies which we have referenced in the text. We also included greater detail on the analysis of the primary outcomes on page 21, paragraph 2, line 9-12. Secondary outcomes and measures are described in table 2 as well. We have included the level of detail similar to other published protocols in BMJ open but would defer to the editors" preference if more precise description is desired.
6. Methods-planned analyses> Please include: How are you planning on dealing with missing data, which covariates that will you adjust for? And how were these selected? Which software are you using? What summary measures are you planning on presenting?
We intend to use multiple imputation to deal with missing data, as described on page 22, 2nd full paragraph, lines 2-5. Covariates to be controlled are listed in Table 3 in the manuscript; see also our response to Reviewer 5 / Question 10. We have included the specific software we will be using on page 22, paragraph 1, lines 1-2 and the last line on page 23.
Sample size calculation
The sample size has a number of weaknesses. Firstly, I would anticipate clustering within sites, as surgeons at similar sites will see a similar case-mix of patients and have access to similar MDT. However, this will vary across sites. This second multi-level needs to be accounted for in the sample size and the ICC for the sites needs to be considered and included. At present the calculation is unclear and should also consider the loss of power due to unbalanced. A few references below will help and are more informative than the reference source currently stated which are very dated and not related to cRCTs.
http://www.abdn.ac.uk/hsru/research/delivery/behaviour/methodological-research/ http://bmcmedresmethodol.biomedcentral.com/articles/10.1186/1471-2288-11-102
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382318/ Thank you for mentioning these key points. In fact, our analysis plan and sample size calculation dealt with many of them, but we may not have been completely clear on those points. As to clustering within sites, both our analysis plan and sample size calculation includes fixed effect terms for site, time (wave), and site-by-time; so, clustering by site is fully accounted for in the model. We added this on page 24, paragraph 1, line 12-14. Second, in terms of ICC, we are interpreting this as the interclass correlation between the multiple patients of the same surgeon, within any site. Again, we included a surgeon level random effect in both our sample size calculation and in our analysis plan, anticipating somewhere between 5% and 30% of the total variance to be accounted for by surgeon effects (i.e., ICC=0.05 to 0.30). We added this to page 23, paragraph 2, line 7-10. (Interestingly, it turns out that power depends only very weakly on the value of ICC. This is because the stepped wedge design represents a mixture of within-surgeon comparisons (post-intervention to preintervention) and between-surgeon comparisons (intervention versus control surgeons at any given wave, within site).) Finally, regarding the lack of balance in that each site has a different number of surgeons, our sample size calculation fully accounted for this feature of our design. In terms of the method for computing power, the reference we cited (47. Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials 2007;28(2):182-91. doi:10.1016/j.cct.2006.05.007) outlines a general method for computing power based on statistical information, adapted to the stepped wedge design. The formula in that paper does not apply directly to our design because it does not account for multiple sites or for the lack of balance. As such, we extended the method to exactly reflect our multi-site, unbalance, six-wave deign, and based our power on the resulting statistical information from that design.
We have added additional clarity regarding how we addressed clustering within sites and ICC. We worry that further elaboration within the manuscript is more detailed that other published protocols in BMJ Open; however, we are happy to add these addition details from our response above should the editor think this would be of benefit to readers.
Reviewer: 5 Reviewer Name: Stephen Bremner Institution and Country: Brighton and Sussex Medical School, UK Please state any competing interests or state "None declared": None declared 1. I think the title of the paper should include 'stepped-wedge'. The abstract does not mention 'stepped-wedge' either, nor does it mention the number of sites, surgeons or patients to be recruited. I think the abstract should also list the primary outcomes.
Thank you for these suggestions. We have added "Stepped-Wedge" to the title and the abstract. We also included the number of sites and participants in the abstract. The number of sites was already included in line 2 of the methods section of the abstract. We also added detail to clarify the primary outcomes in the Methods section of the abstract.
2. In the introduction, it would be helpful (p4, l18) to know what percentage of the US population is covered by Medicare.
Thank you, we have neglected the international nature of the journal"s audience. In the US, all patients 65 and older are covered by Medicare, thus, studies of Medicare beneficiaries reflect universal observations about patients 65 and older. Although many patients have supplemental health insurance, the bulk of hospital stay and outpatient visits are covered by Medicare for all, thus Medicare data represents this population as a whole. While many Americans are seemingly confused on this point, we do have a single-payer government sponsored program for all citizens age 65 and older. We have substituted "patients age 65 and older" for Medicare beneficiaries to decrease this confusion.
3. (p6, l4) Patients due to undergo neurosurgical procedures were included in the initial sample of 90. Why does the trial population not include patients due to undergo such procedures (or are do they come under the vascular umbrella?).
Thank you for allowing us to clarify this important point. Neurosurgical procedures are included in this study. Page 11, first full paragraph, line 1-2 defines high risk vascular surgery as peripheral, neurologic, or cardiovascular procedures.
4. In the eligibility criteria, it is unclear how patients with sight or hearing problems would be accommodated in the study.
We clarified that that vision sufficient to read a newspaper is one of the eligibility criteria on page 11, paragraph 1, line 9 and page 12 line 1-2. We do not outline specific criteria for hearing problems, however we do require that eligible participants be able to converse with the surgeon without an interpreter (aside from Spanish-speaking patients who may use an interpreter). This would exclude completely deaf patients who presumably would need a sign language interpreter during the consult.
Attrition
We agree that these are real concerns for this study given the nature of the decisions we are interested in. We did allow for attrition in our sample size calculation. That said, it is unlikely patients will be dead during data collection for our primary outcome which is collected during the office visit with the surgeon and one day immediately following over the telephone. One reason we chose to enroll family members in addition to patients is because it allows us to collect data from family members if the patient has died. Surgeons who move to a different institution during the study will be replaced by a surgeon with a similar practice and case mix. While we do anticipate this will happen with one or two surgeons, we do not expect a large proportion of surgeons to leave these institutions during the two-year data collection period. Notably, when we calculated sample size, the variability between surgeons (avatar and Press-Gainey scores) was very small.
6. Will reminder letters be sent to patients who do not return questionnaires? How many attempts will be made to telephone patients?
Telephone administration of all questionnaires is the preferred approach unless the patient has request to complete them electronically. As such, the primary mode of patient contact will be over the telephone and we will not be sending reminder letters. We allow a maximum of 6 contact attempts for each questionnaire and have specified this on page 16, paragraph 1, line 10-11.
7. p13, l54: states that study staff will not be blinded during data collection. However, it is stated that an attempt will be made to insulate study staff from group assignment during data collection. Did the authors mean to write 'patients'? Could study staff be blinded whilst collecting chart review data?
This is correct as written. Unfortunately, this is a single blind study for several reasons. The most significant reason is that the intervention requires surgeon endorsement of the QPL. Phyllis Butow"s work has demonstrated that QPLs alone without physician endorsement are ineffective and that the intervention is best when highly endorsed by the surgeon.7 Although the QPL comes with a letter personalized by the patient"s surgeon encouraging the patient to ask questions, study staff send surgeons in the intervention group regular reminders to endorse the QPL during visits with all new patients in an effort to achieve the type of endorsement that Butow has observed is necessary. Thus, both study staff and surgeons are not blinded to the intervention group. Furthermore, study staff are tasked with assuring the QPL has been sent and check to see if it has been received with the first questionnaire administered one day after the patient has enrolled. Only patients and family members are blinded to the objectives of the study regarding the QPL intervention. During data collection, we will make every attempt to insulate study staff from the group assignment; specifically, all questionnaires will be administered before study staff inquire about receipt of the QPL. To ensure accuracy of chart review data collection, we have a second blinded clinician perform a quality control check of entered data on 10% of the sample. We have clarified this on page 13, paragraph 2.
8. There are four primary outcomes, yet the Bonferroni correction is applied for two hypothesis tests. Should it not be applied for four?
Thank you for this question. Briefly, we applied the Bonferroni correction to two hypothesis tests because we did the calculation for each aim separately. There are two primary outcomes for each of Aim 1 and Aim 2. The two aims reflect the fact that there are two scientific questions being addressed; one for each of the two aims. Our philosophy is that we should not correct for multiple comparisons across scientific questions, but only across tests within a set of tests all pertaining to the same scientific question. Within each question, we fully agree that correction for multiple comparisons should be made so as to provide a statistically valid conclusion relative to that question based on the data. Hence, the Bonferroni correction for two tests. This is indicated on page 23, second full paragraph.
To further clarify, we also added "Aim 1" and "Aim 2" to the section headers for Patient Engagement and Psychological Wellbeing as well as to Table 2 on page 17.
9. In table 3, the abbreviation MD is used. Please add a footnote to say this means 'medical doctor'.
Thank you, we have now included this footnote.
10. On p20, l20-23: it is stated that covariates will be used to increase precision of the treatment effect estimate. Are these the covariates listed in table 3? If so, how were they chosen? The addition of covariates to a logistic model does not increase the precision of the estimated treatment effect. On p21, l11, are cofactors the same thing as covariates?
You are correct. The covariates are listed in table 3. We changed cofactors to covariates in response to your comment regarding page 22. Whereas there does appear to be some disagreement on this point, we agree with the reviewer that adjusting for covariates in anything besides linear regression for a continuous outcome is likely to decrease, not increase, the precision of the treatment effect estimates. As such, we modified our plan to say for linear models, we will adjust for the pre-specified list of covariates in Table 3 and that for logistic and other models, we will not adjust (page 21, first full paragraph line 11-12).
11. In the 2nd paragraph on page 21, multiple imputation is mentioned but it is not stated whether this will be multilevel imputation.
Thank you for pointing out that our plan for imputation needs a little clarity. Indeed, we do not know the exact plan for imputation because we do not know what the extent and nature of the missingness patterns will be. Will there be some surgeons who have quite a bit more missingness than others? Will items tend to be missing more than entire data on patients? When it comes time for analysis, we will develop a comprehensive description of the missingness patterns and develop a plan for imputation that leverages the available data and that concentrates on the parts of the data most heavily subject to missingness. For example, if items tend to be missing intermittently, we will rely on other items from each subject to generate imputations for the missing items. Alternatively, if data on entire patients tend to be missing, we will consider a modeling plan where other patients from the same surgeon and/or site are leveraged to impute data for the missing patients. In any case, we will conduct sensitivity analyses to our assumptions about the missing data mechanisms. We have added an additional sentence to clarify this on page 22, paragraph 2, lines 2-5.
12. In the first paragraph of the sample size calculation section, it is stated that the total number of possible participants is 1000. However, I can only count 904: 480 patients + 384 family members + 40 surgeons.
Thank you for this question. The maximum possible enrollment number of 1000 was reached by assuming that every patient will enroll as a dyad with a family member so the total is 480 patients + 480 family member + 40 surgeons = 1000. We do not anticipate that each patient will enroll with a family member but this is the theoretical maximum number of participants. We have added a sentence to clarify on page 23, first full paragraph, line 5.
13. What software did the authors use to calculate the sample sizes and what will they use to undertake the analyses?
We chose not to modify Figure 3 as this image describes the timing of the questionnaires, not approach A or B. For example, some surgeons who usually make a treatment decision with patients on the first visit could defer a decision until additional testing is obtained. We will still only audiorecord the first visit with the surgeon, but the timing of the administration of the questionnaires would be determined based on the right side of the figure.
18. There is no mention of the CONSORT statement (extension to cluster randomised trials) in terms of trial reporting.
Thank you for pointing this out. We have added a statement at the end of the paragraph on page 26 and first 2 lines of page 27.
19. There is no mention of the database software that will be used for the trial database and how data will be quality checked.
We are using REDCap database software and have now indicated this on page 16, paragraph 2, line 3-5. Data quality checks are described on page 14, paragraph 2, lines 13-14.
20. Typos: p9, l6: remove one 'in' footnote to table 1: patient should be patients p11, l35: 'condition' should be 'conditions'
Thank you, we have corrected all of the above typos.
